AngioDynamics, Inc.
ANGO · FY2026 · Fiscal year ended May 31, 2026 · 10-K filed Jul 2026
Open the dashboardInfographicSummary
FY2026 key figures
| $ | FY2026 | FY2025 | Change |
|---|---|---|---|
| Revenue | $320M | $292M | +9.5% |
| Operating income | −$39.9M | −$40.0M | +0.1% |
| Net income | −$36.7M | −$34.0M | −8.1% |
Latest quarter: Q1 FY2027
Form 10-Q · Three months ended Aug 31, 2026 · filed Oct 8, 2026
| $ | Q1 FY2027 | Year earlier | Change |
|---|---|---|---|
| Revenue | $80.9M | $75.7M | +6.9% |
| Operating income | −$7.30M | −$10.7M | +31.8% |
| Net income | −$7.10M | −$10.9M | +34.9% |
Q1 FY2027 dashboardQ1 FY2027 infographic
Questions
- What was AngioDynamics's revenue in FY2026?
- $320M in FY2026 (Fiscal year ended May 31, 2026), +9.5% vs $292M a year earlier, per its 10-K filed Jul 2026.
- Was AngioDynamics profitable in FY2026?
- No: net income was −$36.7M and operating income −$39.9M in FY2026.
- What was AngioDynamics's revenue in Q1 FY2027?
- $80.9M (+6.9% vs a year earlier), per its Form 10-Q filed Oct 8, 2026.